WATERLOO, Ontario, 20 July 2026 – KA Imaging has expanded its international footprint with regulatory approvals in Thailand and Singapore for its Reveal 35C detector with SpectralDR® technology, enabling commercialization of the company's spectral X-ray platform in two important Southeast Asian healthcare markets.
The approvals, granted by the Thailand Food and Drug Administration (Thai FDA) and the Health Sciences Authority (HSA) of Singapore, represent an important milestone in KA Imaging's Asia-Pacific growth strategy and broaden access to the company's single-exposure spectral X-ray technology across the region.
In Thailand, the approval allows KA Imaging's local partner, BJC Healthcare, to distribute the Reveal 35C detector across the country. In Singapore, the approval enables KA Imaging's local partner, Eye-2-Eye Communications Pte Ltd, to commercialize and distribute the Reveal 35C detector, expanding access to the company's spectral X-ray technology for healthcare providers across the country.
Ad Statistics
Times Displayed: 374168
Times Visited: 21146 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The milestone represents an important step in KA Imaging's growth across the Asia-Pacific region, where healthcare providers continue to invest in advanced imaging technologies that can provide additional clinical information while maintaining existing radiography workflows.
The Reveal 35C detector features KA Imaging's patented SpectralDR® technology, which simultaneously produces standard digital radiography, soft tissue, and bone images from a single X-ray exposure. By separating anatomical structures at the time of image acquisition, the technology provides clinicians with additional image information alongside a conventional radiograph.
"Thailand and Singapore are important healthcare markets and key parts of our strategy for expanding access to SpectralDR® technology throughout Asia-Pacific," said Amol Karnick, President and CEO of KA Imaging. "These regulatory approvals mark another milestone in our international growth and reflect increasing demand for advanced imaging solutions that integrate seamlessly into existing clinical workflows."
The approvals build on growing international interest in spectral X-ray imaging and follow continued clinical and commercial momentum for KA Imaging's technology. Reveal 35C systems are being used in hospitals, mobile imaging programs, and global health initiatives around the world, including deployments supporting tuberculosis visualization efforts in Kenya and Nigeria.
